Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2
National Institutes of Health · National Cancer Institute
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
2,522
total citations
- FWCI
- 37.90
- Percentile
- 100%
- References
- 66
Citations per year
Authors
6- RARichard A. MorganCorresponding
National Institutes of Health, National Cancer Institute
- JCJames C. Yang
National Institutes of Health, National Cancer Institute
- MKMio Kitano
National Institutes of Health, National Cancer Institute
- MEMark E. Dudley
National Institutes of Health, National Cancer Institute
- CMCarolyn M. Laurençot
National Institutes of Health, National Cancer Institute
Topics & keywords
Topics
Keywords
- Chimeric antigen receptor
- Antigen
- Adverse effect
- Event (particle physics)
- Administration (probate law)
- Receptor
- Virology
- Adverse Event Reporting System
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.